Lapaquistat acetate

DRUG6 trials

Sponsors

Takeda

Conditions

DyslipidemiaHypercholesterolemia

Phase 2

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

TerminatedNCT00865228

TakedaHypercholesterolemia

Start: 2007-07-31End: 2007-11-30Updated: 2012-05-24

Phase 3

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

CompletedNCT00143663

TakedaDyslipidemia

Start: 2005-09-30End: 2006-04-30Updated: 2012-05-24

Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

CompletedNCT00268697

TakedaHypercholesterolemia

Start: 2005-10-31End: 2007-01-31Updated: 2012-05-24

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

CompletedNCT00487994

TakedaDyslipidemia

Start: 2004-11-30End: 2007-05-31Updated: 2012-05-24

Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

TerminatedNCT00532558

TakedaHypercholesterolemia

Start: 2007-10-31End: 2008-05-31Updated: 2012-05-24

Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia

CompletedNCT00868127

TakedaHypercholesterolemia

Start: 2005-12-31End: 2007-07-31Updated: 2012-05-24

Related Papers

Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia.

2011-04-2552 citations